Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Panchaxari M Dandagi"'
Autor:
Sujeet Patil, Panchaxari M. Dandagi, Taufik Kazi, Sujay Hulyalkar, Prakash Biradar, Vijay Kumbar
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 10, Iss 1, Pp 1-19 (2024)
Abstract Background The objective of this current research was to enhance the topical delivery of Nadifloxacin (NDFX) by incorporating it into a transethosomal gel formulation. NDFX has limited penetration into the deep layer of the skin because it i
Externí odkaz:
https://doaj.org/article/35c7fa1281a84a1ba40c03ae76cc02b2
Autor:
Abhijit S. Salokhe, Shubham Malkar, Shubham Mangule, M. S. Palled, Shailendra S. Suryawanshi, Panchaxari M. Dandagi
Publikováno v:
Biomedical and Pharmacology Journal. 15:1337-1348
The objectives of present research work was to develop simple, precise, accurate, specific, cost effective, validated UV-spectrophotometric method for quantification of Agomelatin (AGM) in bulk and pharmaceutical tablets dosage form by Area Under Cur
Publikováno v:
Journal of Pharmaceutical Innovation. 18:238-246
Publikováno v:
Journal of Chromatographic Science.
An innovative RP-HPLC technique was devised to simultaneously quantify thymoquinone (TQ) and capecitabine (CAP) in newly designed polymeric nanoparticles. A unique chromatographic approach was created, optimized and validated using Design-Expert® (d
A fixed-dose combination of diacerein and aceclofenac (ACF) is commonly used in the treatment of osteoarthritis for their disease-modifying and analgesic effects, respectively. We introduce a simple, fast, sensitive, and green HPLC method for synchro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6369e9825be163f4e95bd32102bbe238
Publikováno v:
International Journal of Applied Pharmaceutics. :1-18
Popular cancer therapies face extreme disadvantages, including multimedicament tolerance and non-target impact. These issues will lead to poorer patient conformity and poor levels of survival. Successful medical therapies for cancer patients are desp
Publikováno v:
Journal of Pharmaceutical Innovation.
Autor:
Kishori P. Sutar, Nisha S. Shirkoli, Prasanna S. Sutar, Bhaskar K. Kurangi, Panchaxari M. Dandagi, Rajashree Masareddy
Publikováno v:
Current drug delivery.
Abstract: Oral squamous cell carcinoma is a malignant disease that is causing considerable mortality worldwide. Conventional treatment approaches, like surgery, cause destructive alterations in facial appearance and oral function impairments associat
Publikováno v:
International Journal of Pharmaceutical Research. 12
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::64380fd1dc452de982fbd375599f0c24
http://www.scopus.com/inward/record.url?eid=2-s2.0-84877745197&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84877745197&partnerID=MN8TOARS